| Mrs Jennifer Gillett, LMFT | |
|
317 Seven Springs Way, Suite 203, Brentwood, TN 37027-4575 | |
| (615) 481-5901 | |
| Not Available |
| Full Name | Mrs Jennifer Gillett |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 317 Seven Springs Way, Brentwood, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013284405 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 910 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jennifer Gillett, LMFT 5625 Cloverland Park Dr, Brentwood, TN 37027-1735 Ph: (615) 481-5901 | Mrs Jennifer Gillett, LMFT 317 Seven Springs Way, Suite 203, Brentwood, TN 37027-4575 Ph: (615) 481-5901 |
News Archive
Cell Therapeutics, Inc. (CTI) announced today that it concluded an agreement with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) in Germany for PIXUVRI® (pixantrone).
A new type of brain scan, called diffusion tensor imaging (DTI), appears to be better at detecting whether a person with memory loss might have brain changes of Alzheimer's disease, according to a new study published in the January 6, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida have found that when given together, a two-drug combination acts synergistically in test animals modeled with sarcoma tumors.
Seven out of ten female preschool teachers suffer from sound-induced auditory fatigue, one out of two has difficulty understanding speech and four out of ten become hypersensitive to sound. This is a considerably higher share than among women in general and also higher than in occupational groups exposed to noise, according to research at Sahlgrenska Academy, Sweden.
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). The study will evaluate ANA598 over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, in treatment naive HCV patients. ANA598 is an investigational, oral, non-nucleoside polymerase inhibitor.
› Verified 5 days ago
Johanna Moman Powell, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1661 Mallory Ln, Brentwood, TN 37027 Phone: 615-335-3328 | |
Abigail Elizabeth Myers, MMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5409 Maryland Way Ste 202, Brentwood, TN 37027 Phone: 615-373-9955 Fax: 615-373-2001 | |
Dr. Elizabeth Parrot, PHD Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5409 Maryland Way Ste 202, Brentwood, TN 37027 Phone: 615-373-9955 | |
Tara Hinman, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1604 Westgate Cir, Suite 250, Brentwood, TN 37027 Phone: 615-519-7156 | |
Victoria Valdez, LMFT1944 Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 7105 Peach Ct Ste 110, Brentwood, TN 37027 Phone: 615-669-5242 | |
Dara Russell, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1004 Falling Leaf Cir, Brentwood, TN 37027 Phone: 615-414-3775 |